UHS acquires Emergent Group and PRI Medical

Universal Hospital Services, Inc. ("UHS"), a leading provider of medical equipment management and service solutions, today announced the completion of its acquisition of Emergent Group Inc. ("Emergent Group") (NYSE Amex LLC: LZR) and its wholly owned subsidiary, PRI Medical Technologies, Inc. ("PRI Medical"), a leading provider of mobile medical lasers and surgical equipment. The combined companies will take a leadership role in reducing costs and improving outcomes for hospitals and surgery centers.

UHS announced yesterday the successful completion of its tender offer to purchase the outstanding shares of common stock of Emergent Group, which expired on Wednesday, March 30, 2011. UHS today consummated the short-form merger, and Emergent Group became a wholly owned subsidiary of UHS.

"The acquisition of PRI Medical marks a significant step for UHS to expand our health care solutions that help customers reduce costs, increase efficiencies and drive better outcomes," said Gary Blackford, Chairman and CEO of UHS. "PRI Medical's state-of-the-art laser technology and established commitment to world-class customer service provide a great opportunity to begin to grow and expand these services nationally to meet the growing needs of our customers."

PRI Medical currently operates in 16 states and provides surgical equipment and laser technology to hospitals, outpatient surgery centers and physicians' offices. The equipment is supplied with specialized technicians who support its proper operation and maintenance.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Collaborative project seeks to close diagnostic gap in asthma care